GREENLAND Organic Medical Products Inc.

Markham, ON L3P5J7, Canada


This opportunity is NOW CLOSED.

GREENLAND ORGANIC MEDICAL PRODUCTS INC. ( is a Federally Registered Organic Pharmaceutical Producer targeting what Health Canada calls a “rising medical crisis”. This project's focus is the commercial production of clinically-established medical treatments in the form of raw and processed cannabis, concentrates, oils, CBD/THC tablets, teas and more.

GREENLAND is pursuing ISO standardization, and Health Canada licensing to produce all raw cannabis and medicinal organics in-house to best manage quality control. The corporation is employing a unique, industry-changing Organic Growth Patent (2016 IIP) to meet commercial demand. Agriculture and Agri-Food Canada has noted their growth model can consistently and sustainably produce 6-8 TIMES MORE CANNABIS PER SQUARE FOOT at less cost than conventional methods in use today. GREENLAND is launching this initiative with 1.3 million square feet of year-round growth-space, processing buildings, and dedicated lab facilities.

Recognized as (1) the world's first SUPER-PRODUCER of clean, organically grown-for-purpose cannabis crops, and (2) whereby evaluated/acknowledged by Agriculture and Agri-Food Canada, CIBC Corporate, and EquityNet Analytics, the following is accurate:

* Scalable and profitable to initiate at $5 million USD
* First-year yields between 10.1 - 11 tonnes, with under 10% operational costs.
* Gross production doubling every 2-3 years, or exponentially as per market demand.
* Completely self-sufficient power and fuel generation, within 5 years.
* Medicinal production, institutional partnerships, and expansion grows accordingly.
* EXPONENTIAL-scales of Return On (principal) Investment are available with this opportunity.

General Information


Social Links

Company Industry

Select Industry:

Company Description

0 / 250
0 / 2000


Prior Year Revenue Current Year Revenue Next Year Revenue
Company Age Employees Sub-Industry
3 years, 10 months 30 Nutrition & Other Health-Related Products
Company Type Stock Exchange Stock Symbol
Privately-Held - -

Company Financials

Viewable by EquityNet investors only

Company Age & Size

Stock Exchange

Is this company privately-held or publicly-traded?

Products / Services

0 / 1000
Membership Distribution: Balanced client growth and production

GREENLAND serves individual patients, commercial, and healthcare entities that require an uninterrupted, high turnover supply of clinically-efficative treatments while demanding unprecedented safety standards and accessibility (reliably available at fractional cost).

TYPE I MEMBERSHIP: Medical and Commercial Distribution Memberships

- Secured fractional pricing (largest stable margins, regardless of market variance)
- Supply on demand (keep shelves full & never run out of popular items)
- Unmatched quality assurance (reliable, federally trusted, and safe)
- Secure and personalized account management

TYPE II MEMBERSHIP: Production Care and Acess Program (PCAP) for individual patients.

- Secured lowest pricing below retail MSRP. May be subject to health insurance coverage.
- Always available treatment specific formulations, in client-preferred formats and options.
- Unmatched quality assurance (reliable, federally trusted, and safe)
- Secure and personalized account management

In-House Production Of Safe, Clinically-Proven/Established Medical Treatments:

From over 18,000 acreditted clinical studies and consensus of treatment outcomes, GREENLAND has identified a scheduled range of effective treatment options under their own respective medical programs. In regions outside of Canada and where lawfully permitted, these include:

CLASS (1-4) PRESCRIPTION MEDICINES (Treatment Formulations With MSRP)
-Life-saving treatments, maintenance, and recovery.

-Health & Wellness
-Personally Declared For Medical Use* Products.

Consumer Supply Chain Support (Commercial Only)
-PureDose THC and CBD Decarboxylated Tabs (3000mg - 05mg).
-Dedicated Production of Select Raw or Dried Heritage and Hybrid Cannabis Strains.

Diversity Of Medication Options
-Lifestyle, health and age-appropriate dosage options.


0 / 1000
Managing Director Executive Officer
Roy McLeish

Roy McLeish

Managing Director Executive Officer
Kevin La-Rose

Kevin La-Rose

Associate Executive Officer
Dr. Gebremichael Gebremariam, PhD

Dr. Gebremichael Gebremariam, PhD ASSOCIATE BOTANICAL OFFICER
Possessing over thirty years of applied horticultural and botanical sciences throughout various United Nations food production, organic seed-strain preservation and protection initiatives, doctor Gabremariam is an important contributor towards the corporation’s success.

Acting as Greenland’s organic engineer and overseer, he contributes a lifetime of knowledge to ensure quality, quotas and growth schedules are executed flawlessly.

Senior Science/Scientist
Dr. Andrew ****, PhD

Dr. Andrew *** contributes his 25+ years of expertise as a Senior Research Scientist for Merck Pharmaceuticals (USA), to ensure Greenland product quality and standards are met.

Director Quality Assurance
Pedro ********

Pedro contributes his 25 years of adept logistics management with Canadian Blood Services to ensure all of Greenland’s needs are met.

Investors / Lenders

Add investors/lenders that are already on EquityNet by typing their name and then selecting them from the drop-down.
Add investors/lenders that are not yet on EquityNet by typing their name, selecting "Add a New Investor", and filling in additional information.


To find out if this company and others are accepting funding, .

Funding Goal$5,000,000

Funding Raised So Far$0

Funding Commitments$7,500,000

Funding Remaining$0

Funding TypeDebt Financing

Pre-Money Valuation

Investor Ownership

Interest / Dividend

Previous Funding

General Funding

Showing your General Funding information publicly may constitute general solicitation. General solicitation is a new commonly-used way for companies to raise funding. To learn about general solicitation, consult your legal counsel. If you uncheck this box, your General Funding information will be viewable to only EquityNet investors.

Private Funding

Viewable by EquityNet investors only


GREENLAND Organic Medical Products Inc. Image 1
GREENLAND Organic Medical Products Inc. Image 2
GREENLAND Organic Medical Products Inc. Image 3
GREENLAND Organic Medical Products Inc. Image 4
GREENLAND Organic Medical Products Inc. Image 5
GREENLAND Organic Medical Products Inc. Image 6



Complete a Business Plan in EquityNet

Your EquityNet business plan is only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. Investors prefer an EquityNet business plan. Entering a plan is highly educational and improves your appeal to investors.

Upload Documents

Document file names will be viewable by EquityNet investors and business supporters only. Actual documents are only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab.

Share Your Public Profile Page

Users who follow all these tips increase their fundraising odds substantially.

  • Email your public page to all your LinkedIn contacts.
    • Post your page to your LinkedIn profile page.
  • Email your public page to all your Facebook contacts.
    • Post your page to your Facebook profile page.
  • Email your public page to all your Twitter contacts.
    • Post your page to your Twitter profile page.
  • Put your public page up on your website.
    • Don't have a website yet? Use this page as your site!
  • Share your page link anywhere there's a listing for your company.
    • Press Releases, Crunchbase, Wikipedia, Blogs, etc...
  • Email your public page to all your email contacts.
    • Use Outlook, Gmail, Yahoo Mail, Hotmail, etc...

Your Public Profile Page:

Would you like to share your public profile page with your email contacts?